• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒性呼吸道感染和新冠肺炎的心血管并发症

Cardiovascular Complications of Viral Respiratory Infections and COVID-19.

作者信息

Franczuk Paweł, Tkaczyszyn Michał, Kulak Maria, Domenico Esabel, Ponikowski Piotr, Jankowska Ewa Anita

机构信息

Institute of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Institute of Heart Diseases, University Hospital, 50-556 Wroclaw, Poland.

出版信息

Biomedicines. 2022 Dec 27;11(1):71. doi: 10.3390/biomedicines11010071.

DOI:10.3390/biomedicines11010071
PMID:36672579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9856218/
Abstract

Viral respiratory infections (VRI) are the most prevalent type of infectious diseases and constitute one of the most common causes of contact with medical care. Regarding the pathophysiology of the cardiovascular system, VRI can not only exacerbate already existing chronic cardiovascular disease (such as coronary artery disease or heart failure) but also trigger new adverse events or complications (e.g., venous thromboembolism), the latter particularly in subjects with multimorbidity or disease-related immobilization. In the current paper, we provide a narrative review of diverse cardiovascular complications of VRI as well as summarize available data on the pathology of the circulatory system in the course of coronavirus disease 2019 (COVID-19).

摘要

病毒性呼吸道感染(VRI)是最常见的传染病类型,也是就医的最常见原因之一。关于心血管系统的病理生理学,VRI不仅会加重已有的慢性心血管疾病(如冠状动脉疾病或心力衰竭),还会引发新的不良事件或并发症(如静脉血栓栓塞),后者在患有多种疾病或因病制动的患者中尤为常见。在本文中,我们对VRI的各种心血管并发症进行了叙述性综述,并总结了2019冠状病毒病(COVID-19)病程中循环系统病理学的现有数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/606156f7bd4c/biomedicines-11-00071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/3ddc9dbbb49b/biomedicines-11-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/ff39ed5615eb/biomedicines-11-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/606156f7bd4c/biomedicines-11-00071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/3ddc9dbbb49b/biomedicines-11-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/ff39ed5615eb/biomedicines-11-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984b/9856218/606156f7bd4c/biomedicines-11-00071-g003.jpg

相似文献

1
Cardiovascular Complications of Viral Respiratory Infections and COVID-19.病毒性呼吸道感染和新冠肺炎的心血管并发症
Biomedicines. 2022 Dec 27;11(1):71. doi: 10.3390/biomedicines11010071.
2
Cardiovascular impact of COVID-19 with a focus on children: A systematic review.新冠病毒病对心血管系统的影响(聚焦于儿童):一项系统综述
World J Clin Cases. 2020 Nov 6;8(21):5250-5283. doi: 10.12998/wjcc.v8.i21.5250.
3
Cardiovascular complications in COVID-19.COVID-19 中的心血管并发症。
Am J Emerg Med. 2020 Jul;38(7):1504-1507. doi: 10.1016/j.ajem.2020.04.048. Epub 2020 Apr 18.
4
COVID-19 and its long-term impact on the cardiovascular system.新型冠状病毒肺炎及其对心血管系统的长期影响。
Expert Rev Cardiovasc Ther. 2023 Mar;21(3):211-218. doi: 10.1080/14779072.2023.2184800. Epub 2023 Mar 6.
5
Approach to Acute Cardiovascular Complications in COVID-19 Infection.COVID-19 感染的急性心血管并发症处理方法。
Circ Heart Fail. 2020 Jul;13(7):e007220. doi: 10.1161/CIRCHEARTFAILURE.120.007220. Epub 2020 Jun 5.
6
Inferior Wall Myocardial Infarction in Severe COVID-19 Infection: A Case Report.重症新型冠状病毒肺炎感染合并下壁心肌梗死:一例报告
Am J Case Rep. 2020 Sep 28;21:e926101. doi: 10.12659/AJCR.926101.
7
COVID-19-induced cardiovascular damage differs from other prevalent viruses.新冠病毒(COVID-19)引发的心血管损伤不同于其他常见病毒。
Cardiol Plus. 2021 Oct 1;6(4):231-245. doi: 10.4103/2470-7511.334401. Epub 2021 Dec 30.
8
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.急性 COVID-19 心血管综合征的描述与处理建议。
Circulation. 2020 Jun 9;141(23):1903-1914. doi: 10.1161/CIRCULATIONAHA.120.047349. Epub 2020 Apr 16.
9
SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.SARS-CoV-2 感染(COVID-19)与非洲心血管疾病:医疗保健和社会经济影响。
Glob Heart. 2021 Mar 15;16(1):18. doi: 10.5334/gh.829.
10
COVID-19 and the Cardiovascular System.新型冠状病毒肺炎与心血管系统
Crit Care Nurs Q. 2020 Oct/Dec;43(4):381-389. doi: 10.1097/CNQ.0000000000000323.

引用本文的文献

1
Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.基于二价呼吸道合胞病毒预融合F蛋白的疫苗预防老年人心血管疾病住院治疗:DAN-RSV试验的预设分析
JAMA. 2025 Aug 30. doi: 10.1001/jama.2025.15405.
2
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Norway between 2010 and 2019: A Time-Series Modelling Study.2010年至2019年挪威成人呼吸道合胞病毒感染所致住院和死亡的估计发病率:一项时间序列建模研究
J Epidemiol Glob Health. 2025 Aug 14;15(1):107. doi: 10.1007/s44197-025-00448-0.
3

本文引用的文献

1
Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review.子痫前期与严重急性呼吸综合征冠状病毒 2 感染:系统评价。
J Hypertens. 2022 Sep 1;40(9):1629-1638. doi: 10.1097/HJH.0000000000003213. Epub 2022 Jul 22.
2
Usefulness of CHEST Score in Predicting Clinical Outcomes of COVID-19 in Heart Failure and Non-Heart-Failure Cohorts.CHEST评分在预测心力衰竭和非心力衰竭队列中COVID-19临床结局方面的效用。
J Clin Med. 2022 Jun 17;11(12):3495. doi: 10.3390/jcm11123495.
3
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019.
2015年至2019年德国成年人中因呼吸道合胞病毒导致的特定类型心血管和呼吸系统住院的估计发病率
Influenza Other Respir Viruses. 2025 May;19(5):e70097. doi: 10.1111/irv.70097.
4
Detection by Nasopharyngeal Swabs Alone Underestimates Respiratory Syncytial Virus-Related Hospitalization Incidence in Adults: The Multispecimen Study's Final Analysis.仅通过鼻咽拭子检测会低估成人呼吸道合胞病毒相关住院发病率:多样本研究的最终分析
J Infect Dis. 2025 Jul 30;232(1):e126-e136. doi: 10.1093/infdis/jiaf204.
5
Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.肺部疾病与病毒感染之间的相互作用:综述
Microorganisms. 2024 Oct 8;12(10):2030. doi: 10.3390/microorganisms12102030.
6
Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness-Valencia Region, Spain, 2010-2021.2010-2021 年西班牙巴伦西亚地区急性呼吸道疾病住院患者中呼吸道病毒感染的季节性和共检出情况。
Influenza Other Respir Viruses. 2024 Oct;18(10):e70017. doi: 10.1111/irv.70017.
7
Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia.皮质类固醇治疗病毒性社区获得性肺炎患者的疗效
Pneumonia (Nathan). 2024 Sep 25;16(1):21. doi: 10.1186/s41479-024-00146-8.
8
A Model-Based Estimation of RSV-Attributable Incidence of Hospitalizations and Deaths in Italy Between 2015 and 2019.基于模型对2015年至2019年意大利因呼吸道合胞病毒导致的住院和死亡发病率的估计。
Infect Dis Ther. 2024 Nov;13(11):2319-2332. doi: 10.1007/s40121-024-01041-x. Epub 2024 Sep 18.
9
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022.2010 - 2022年西班牙巴利亚多利德住院成人呼吸道合胞病毒风险概况及与流感和新冠病毒对照的比较
Infect Dis Ther. 2024 Sep;13(9):1983-1999. doi: 10.1007/s40121-024-01021-1. Epub 2024 Jul 21.
10
Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019.2013年至2019年间加拿大安大略省成人因呼吸道合胞病毒感染导致的住院估计发病率。
Infect Dis Ther. 2024 Sep;13(9):1949-1962. doi: 10.1007/s40121-024-01018-w. Epub 2024 Jul 15.
长新冠:聚焦心血管的 COVID-19 后急性后遗症。
Eur Heart J. 2022 Mar 14;43(11):1157-1172. doi: 10.1093/eurheartj/ehac031.
4
Could SARS-CoV-2 infection affect male fertility and sexuality?新冠病毒感染是否会影响男性生育能力和性功能?
APMIS. 2022 May;130(5):243-252. doi: 10.1111/apm.13210. Epub 2022 Mar 5.
5
Anticoagulation Prior to COVID-19 Infection Has No Impact on 6 Months Mortality: A Propensity Score-Matched Cohort Study.新冠病毒感染前的抗凝治疗对6个月死亡率无影响:一项倾向评分匹配队列研究。
J Clin Med. 2022 Jan 12;11(2):352. doi: 10.3390/jcm11020352.
6
History of Heart Failure in Patients Hospitalized Due to COVID-19: Relevant Factor of In-Hospital Complications and All-Cause Mortality up to Six Months.因新冠病毒疾病住院患者的心力衰竭病史:院内并发症及长达六个月全因死亡率的相关因素
J Clin Med. 2022 Jan 3;11(1):241. doi: 10.3390/jcm11010241.
7
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme.主要非住院的 SARS-CoV-2 感染者的多器官评估:汉堡城市健康研究 COVID 项目。
Eur Heart J. 2022 Mar 14;43(11):1124-1137. doi: 10.1093/eurheartj/ehab914.
8
Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study.2008 年至 2018 年期间英格兰心血管风险增加的成年人中急性呼吸道感染后急性呼吸道感染和急性心血管事件的风险:一项回顾性、基于人群的队列研究。
Lancet Digit Health. 2021 Dec;3(12):e773-e783. doi: 10.1016/S2589-7500(21)00203-X.
9
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.欧洲心脏病学会在 COVID-19 大流行期间心血管疾病的诊断和管理指南:第 1 部分-流行病学、病理生理学和诊断。
Eur Heart J. 2022 Mar 14;43(11):1033-1058. doi: 10.1093/eurheartj/ehab696.
10
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.在一个国际队列中对长期新冠进行特征描述:7个月的症状及其影响。
EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.